TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

Go back to TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference

Form 8-K TG THERAPEUTICS, INC. For: Nov 09

November 9, 2015 7:36 AM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE... More